These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evidence for a rapid action of levetiracetam compared to topiramate in refractory partial epilepsy. Specchio LM; Boero G; Specchio N; De Agazio G; De Palo A; de Tommaso M; Beghi E; La Neve A Seizure; 2006 Mar; 15(2):112-6. PubMed ID: 16406697 [TBL] [Abstract][Full Text] [Related]
4. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting. Guerrini R; Carpay J; Groselj J; van Oene J; Schreiner A; Lahaye M; Schwalen S; Seizure; 2005 Sep; 14(6):371-80. PubMed ID: 15961326 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study. Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581 [TBL] [Abstract][Full Text] [Related]
6. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308 [TBL] [Abstract][Full Text] [Related]
7. Topiramate slow dose titration: improved efficacy and tolerability. Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117 [TBL] [Abstract][Full Text] [Related]
8. A pooled analysis of adjunctive topiramate in refractory partial epilepsy. Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study. Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083 [TBL] [Abstract][Full Text] [Related]
10. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy. Chmielewska B; Stelmasiak Z Neurol Neurochir Pol; 2008; 42(4):303-11. PubMed ID: 18975234 [TBL] [Abstract][Full Text] [Related]
11. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group. Privitera M; Fincham R; Penry J; Reife R; Kramer L; Pledger G; Karim R Neurology; 1996 Jun; 46(6):1678-83. PubMed ID: 8649569 [TBL] [Abstract][Full Text] [Related]
12. Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy. Groselj J; Guerrini R; Van Oene J; Lahaye M; Schreiner A; Schwalen S; Acta Neurol Scand; 2005 Sep; 112(3):144-50. PubMed ID: 16097955 [TBL] [Abstract][Full Text] [Related]
13. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
14. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Arroyo S; Dodson WE; Privitera MD; Glauser TA; Naritoku DK; Dlugos DJ; Wang S; Schwabe SK; Twyman RE; Acta Neurol Scand; 2005 Oct; 112(4):214-22. PubMed ID: 16146489 [TBL] [Abstract][Full Text] [Related]
16. Topiramate: a new safe and effective antiepileptic. Gupta M; Rehman N; Bansal J; Mogre V J Indian Med Assoc; 2001 Aug; 99(8):449-50. PubMed ID: 11881861 [TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: an observational study. Cho YJ; Heo K; Kim WJ; Jang SH; Jung YH; Ye BS; Song DB; Lee BI Epilepsia; 2009 Aug; 50(8):1910-9. PubMed ID: 19563348 [TBL] [Abstract][Full Text] [Related]
18. Low dose and slow titration of topiramate as adjunctive therapy in refractory partial epilepsies: a multicentre open clinical trial. Korian Topiramate Study Group Seizure; 2002 Jun; 11(4):255-60. PubMed ID: 12027573 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy. Pasha I; Kamate M; Didagi SK Pediatr Neurol; 2014 Oct; 51(4):509-14. PubMed ID: 25266613 [TBL] [Abstract][Full Text] [Related]